1c:{"metadata":[["$","title","0",{"children":"NIH VideoCast - Proteomic Tools for Studying Mitochondrial Dysfunction and Age-Related Diseases"}],["$","meta","1",{"name":"description","content":"The evidence linking mitochondria to normal aging and age-related disorders has increased in recent years. Therefore, it has become increasingly apparent that mitochondrial function and dysfunction need to be probed if these pathologies are to be understood at the cellular level. For example, mitochondrial protein expression profiling of disease tissue from patients with Alzheimer's disease, Parkinson's \ndisease and other mitochondria-linked diseases will be essential to reach a more complete understanding of the role of mitochondria in the progression or etiology of these disorders. Differential patterns in protein expression or posttranslational modifications may reveal novel molecular targets for drug discovery and diagnostic protein markers that could serve as biomarkers of disease and disease progression.

\nFor more information, visit
\nProteome Interest Group
"}],["$","meta","2",{"name":"publisher","content":"National Institutes of Health"}],["$","meta","3",{"property":"og:title","content":"NIH VideoCast - Proteomic Tools for Studying Mitochondrial Dysfunction and Age-Related Diseases"}],["$","meta","4",{"property":"og:description","content":"The evidence linking mitochondria to normal aging and age-related disorders has increased in recent years. Therefore, it has become increasingly apparent that mitochondrial function and dysfunction need to be probed if these pathologies are to be understood at the cellular level. For example, mitochondrial protein expression profiling of disease tissue from patients with Alzheimer's disease, Parkinson's \ndisease and other mitochondria-linked diseases will be essential to reach a more complete understanding of the role of mitochondria in the progression or etiology of these disorders. Differential patterns in protein expression or posttranslational modifications may reveal novel molecular targets for drug discovery and diagnostic protein markers that could serve as biomarkers of disease and disease progression.

\nFor more information, visit
\nProteome Interest Group
"}],["$","meta","5",{"property":"og:url","content":"https://uat.d1rkikwu4q8tg.amplifyapp.com/watch/97b47a9b-d5db-11f0-9cf9-12c45c580ad9"}],["$","meta","6",{"property":"og:site_name","content":"NIH VideoCast"}],["$","meta","7",{"property":"og:image","content":"https://nihcit.rev.vbrick.com/api/v2/media/videos/thumbnails/cf7be3b5-0b12-4852-9aa2-b35982921bef.jpg"}],["$","meta","8",{"property":"og:type","content":"website"}],["$","meta","9",{"name":"twitter:card","content":"summary_large_image"}],["$","meta","10",{"name":"twitter:title","content":"NIH VideoCast - Proteomic Tools for Studying Mitochondrial Dysfunction and Age-Related Diseases"}],["$","meta","11",{"name":"twitter:description","content":"The evidence linking mitochondria to normal aging and age-related disorders has increased in recent years. Therefore, it has become increasingly apparent that mitochondrial function and dysfunction need to be probed if these pathologies are to be understood at the cellular level. For example, mitochondrial protein expression profiling of disease tissue from patients with Alzheimer's disease, Parkinson's \ndisease and other mitochondria-linked diseases will be essential to reach a more complete understanding of the role of mitochondria in the progression or etiology of these disorders. Differential patterns in protein expression or posttranslational modifications may reveal novel molecular targets for drug discovery and diagnostic protein markers that could serve as biomarkers of disease and disease progression.

\nFor more information, visit
\nProteome Interest Group
"}],"$L22","$L23","$L24"],"error":null,"digest":"$undefined"}